| Literature DB >> 29731708 |
José V Negrete-Díaz1,2, Talvinder S Sihra3, Gonzalo Flores4, Antonio Rodríguez-Moreno1.
Abstract
A metabotropic modus operandi for kainate receptors (KARs) was first discovered in 1998 modulating GABA release. These receptors have been also found to modulate glutamate release at different synapses in several brain regions. Mechanistically, a general biphasic mechanism for modulating glutamate release by presynaptic KARs with metabotropic actions has emerged, with low KA concentrations invoking an increase in glutamate release, whereas higher concentrations of KA mediate a decrease in the release of this neurotransmitter. The molecular mechanisms underpinning the opposite modulation of glutamate release are distinct, with a G-protein-independent, adenylate cyclase (AC)- and protein kinase A (PKA)-dependent mechanism mediating the facilitation of glutamate release, while a G-protein dependent mechanism (with or without protein kinase recruitment) is involved in the decrease of neurotransmitter release. In the present review, we revisit the mechanisms underlying the non-canonical modus operandi of KARs effecting the bimodal control of glutamatergic transmission in different brain regions, and address the possible functions that this modulation may support.Entities:
Keywords: G protein; glutamate; kainate receptors; metabotropic; presynaptic; protein kinase A; protein kinase C
Year: 2018 PMID: 29731708 PMCID: PMC5920280 DOI: 10.3389/fnmol.2018.00128
Source DB: PubMed Journal: Front Mol Neurosci ISSN: 1662-5099 Impact factor: 5.639
Figure 1Metabotropic actions of kainate receptors (KARs) in the regulation of glutamate release in the hippocampus. (A) Experimental setup for studies in the hippocampus. (B) Metabotropic actions of KARs at CA3 Schaffer collaterals (SC)-CA1 pyramidal cell (PC) synapses. Schematic of signaling at the SC-CA1 synapse. KARs activation mediate a depression of EPSC amplitudes at SC-CA1 synapses which is abolished in slices treated with pertussis-toxin (PTX). The depression of the EPSC amplitude is not dependent on any protein kinase cascades. (C) Metabotropic action of KARs depressing and facilitating glutamate release at the MF-CA3 synapse. KAR activation by high concentrations of kainate (>100 nM) depresses glutamate release at MF-CA3 synapses, an effect that involves a Gi/o protein and the adenylate cyclase/cAMP/protein kinase A (AC/cAMP/PKA) pathway. KAR activation by low concentrations of kainate (<100 nM) facilitates glutamate release following activation of a Ca2+-calmodulin/AC/cAMP/PKA pathway.
Non-canonical actions of kainate receptors (KARs) on glutamate release.
| Low [KA] | G-protein | PKC | PKA | High [KA] | G-protein | PKC | PKA | ||
|---|---|---|---|---|---|---|---|---|---|
| SC-CA1 | ? | ? | ? | ? | Depression | Yes | No | No | Frerking et al. ( |
| MF-CA3 | Facilitation | No | No | Yes | Depression | Yes | No | Yes | Rodríguez-Moreno and Sihra ( |
| L2/3-L2/3 | Facilitation | ? | ? | ? | Depression | ? | ? | ? | Campbell et al. ( |
| L4-L2/3 | |||||||||
| Synaptosomes | Facilitation | No | No | Yes | Facilitation | No | No | Yes | Rodríguez-Moreno and Sihra ( |
| Facilitation | No | No | Yes | Depression | Yes | No | Yes | Jouhanneau et al. ( | |
| MGN-LA | Facilitation (ATPA) | ? | ? | ? | Depression | ? | No | Yes | Shin et al. ( |
| No effect | Depression | Yes | Yes | No | Jin et al. ( | ||||
| DRG | Depression | ? | ? | ? | Depression | Yes | Yes | ? | Kerchner et al. ( |